Effects of the Colosure Dietary Supplement Product on Muscle, Bone, Immune, Cognitive Function Parameters in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial

Program Management Unit for Competitiveness (PMUC)0 个研究点目标入组 80 人开始时间: 2023年9月28日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Age between 55-70 years
•2. Weight of at least 40.0 kg and body mass index within the range of 18.5-22.9 kg/m2
•3. General good health
•4. Normal cognitive function or mild cognitive impairment
•5. Able to provide written informed consent

•1. Presence of any severe co-morbidity(ies), uncontrolled medical condition(s), or medical illness(es)
•2. History of body metal implants or brachytherapy
•3. History of hypersensitivity to any ingredients in the investigational product
•4. Any other condition(s) in which any ingredients in the investigational product are contraindicated
•5. Any other condition(s) that affects swallowing or consumption of the investigational product
•6. Problem(s) with alcoholism, substance abuse, or heavy smoking
•7. Use of a medication(s), herb(s), dietary supplement(s), or vitamin(s) that is likely to interact with any ingredients in the investigational product
•8. Receives a vaccine(s) within 14 days (for inactivated vaccines) or 30 days (for live vaccines) or plan to receive any vaccines during the study period
•9. Participates in another clinical trial concurrently or within 30 days
•10. Plan to have a baby, or known or suspected pregnancy, or breastfeeding (for female patients)

发起方

Program Management Unit for Competitiveness (PMUC)